Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on April 21, 2025

Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings

Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings

OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant financial improvements resulting from strategic market transitions …

Snail Games Subsidiary Interactive Films LLC Signs MOU with Mega Matrix Inc. (NYSE American: MPU) for Joint Short-Drama Development

Snail Games Subsidiary Interactive Films LLC Signs MOU with Mega Matrix Inc. (NYSE American: MPU) for Joint Short-Drama Development

CULVER CITY, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, announced that its wholly owned subsidiary, …

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

— Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic device (CIED) procedures — SILVER SPRING, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“ …

Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences

Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences

TEL AVIV, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd., (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that clinical …

SoftBank Chain (SBC) Launches Interstellar: Powering the Future of Web3 Payments and Open Finance

SoftBank Chain (SBC) Launches Interstellar: Powering the Future of Web3 Payments and Open Finance

New York, NY, April 21, 2025 (GLOBE NEWSWIRE) -- SoftBank Chain (SBC) has officially launched Interstellar, a groundbreaking solution designed to revolutionize Web3 payments and open finance infrastructure. As a next-generation protocol, Interstellar aims …

Global Surface Plasmon Resonance Market to Reach $1,720.3 Million, by 2032 at 6.5% CAGR: Coherent Market Insights

Global Surface Plasmon Resonance Market to Reach $1,720.3 Million, by 2032 at 6.5% CAGR: Coherent Market Insights

Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global Surface Plasmon Resonance Market size is estimated to grow from US$ 1,107.0 Million in 2025 and is forecast to reach a value of US$ 1,720.3 …

Global Rabies Vaccine Market Set to Witness Steady Growth Through 2032

Global Rabies Vaccine Market Set to Witness Steady Growth Through 2032

Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) -- The global rabies vaccine market size is projected to expand significantly during the forecast period, owing to rising incidence of zoonotic diseases like rabies. By vaccine type, purified chick embryo …

Nano Dimension Provides Update on Desktop Metal

Nano Dimension Provides Update on Desktop Metal

Waltham, Massachusetts, April 21, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today provided an update on Desktop Metal. Desktop Metal, a subsidiary of Nano …

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …

BULGOLD Announces Filing of Fourth Quarter Financial Results for Three and Twelve Months Ended December 31, 2024

BULGOLD Announces Filing of Fourth Quarter Financial Results for Three and Twelve Months Ended December 31, 2024

TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has filed its audited annual financial statements and MD…

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations

ANN ARBOR, Mich., April 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, is pleased to provide an update on recombinant spider silk production. The …

Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facility with …

Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting

Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting

NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that new preclinical combination data …

BioCryst to Report First Quarter 2025 Financial Results on May 5

BioCryst to Report First Quarter 2025 Financial Results on May 5

RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will host a …

Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines

Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines

ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele …

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025

Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025

PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first …

Apellis Announces Craig Wheeler to Join the Board of Directors

Apellis Announces Craig Wheeler to Join the Board of Directors

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective …

Salary.com to Present with Gonzaga University at CUPA-HR Spring Conference

Salary.com to Present with Gonzaga University at CUPA-HR Spring Conference

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- WHO: Garry Straker, Vice President of Compensation Consulting at Salary.com, a leading provider of compensation market data and software     WHAT: Will join Kelsey Gregory, Compensation Analyst, and Kelly …

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402

Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402

Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service